Life-threatening toxic epidermal necrolysis during voriconazole therapy for invasive aspergillosis after chemotherapy.
Curigliano
G
G
Formica
V
V
De Pas
T
T
Spitaleri
G
G
Pietri
E
E
Fazio
N
N
de Braud
F
F
Goldhirsch
A
A
D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use; D000935:Antifungal Agents / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001228:Aspergillosis / Q000188:drug therapy*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000473:pathology; D004347:Drug Interactions; D006801:Humans; D008172:Lung Diseases, Fungal / Q000188:drug therapy*; D008297:Male; D010672:Phenytoin / Q000627:therapeutic use; D011743:Pyrimidines / Q000009:adverse effects*; D013262:Stevens-Johnson Syndrome / Q000209:etiology*; D014230:Triazoles / Q000009:adverse effects*; D065819:Voriconazole
D000927:Anticonvulsants; D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D010672:Phenytoin; D065819:Voriconazole